PubMed

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299. PMID: 11453706 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease.

Kidney Int. 2001 Sep;60(3):1131-40.PMID: 11532109 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Giatras I, Lau J, Levey AS.

Ann Intern Med. 1997 Sep 1;127(5):337-45.PMID: 9273824 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.

Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS; ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group.

Kidney Int. 2005 Jan;67(1):265-71.PMID: 15610250 [PubMed - indexed for MEDLINE]Related articles

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.

Kanno Y, Takenaka T, Nakamura T, Suzuki H.

Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. Epub 2006 May 17.PMID: 17699280 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.PMID: 10845831 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.PMID: 17984482 [PubMed - indexed for MEDLINE]Related articlesFree article

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.PMID: 16797382 [PubMed - indexed for MEDLINE]Related articles

Renal protection and antihypertensive drugs: current status.

Salvetti A, Mattei P, Sudano I.

Drugs. 1999 May;57(5):665-93. Review.PMID: 10353294 [PubMed - indexed for MEDLINE]Related articles

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

[No authors listed]

Lancet. 1997 Jun 28;349(9069):1857-63.PMID: 9217756 [PubMed - indexed for MEDLINE]Related articles

[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]

Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.

Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. Serbian. PMID: 12154518 [PubMed - indexed for MEDLINE]Related articles

Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

Ahmed A.

J Am Geriatr Soc. 2002 Jul;50(7):1297-300.PMID: 12133029 [PubMed - indexed for MEDLINE]Related articles

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials.

Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE.

Am J Kidney Dis. 2000 Apr;35(4):695-707.PMID: 10739792 [PubMed - indexed for MEDLINE]Related articles

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.

Nephrol Dial Transplant. 2003 Oct;18(10):2047-53.PMID: 13679479 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group.

JAMA. 2001 Jun 6;285(21):2719-28.PMID: 11386927 [PubMed - indexed for MEDLINE]Related articlesFree article

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French. PMID: 12467154 [PubMed - indexed for MEDLINE]Related articles